Skip to main content
Clinical Trials/DRKS00032695
DRKS00032695
Recruiting
未知

Implementation of a new treatment scheme for primary knee prosthesis implantations in the German health care system in collaboration with DRV

Medizinische Hochschule Hannover0 sites70 target enrollmentOctober 2, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Patient with advanced osteoarthritis and indication for endoprosthetic joint replacement of the knee joint (knee TEP)
Sponsor
Medizinische Hochschule Hannover
Enrollment
70
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 2, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medizinische Hochschule Hannover

Eligibility Criteria

Inclusion Criteria

  • Indication for primary implantation of a total knee joint endoprosthesis
  • \- Age: 18 \- 80 years
  • \- Patient is gainfully employed

Exclusion Criteria

  • \- ASA 3\-6
  • \- BMI \> 34 kg/m2
  • \- Diabetes mellitus with blood glucose imbalances (hypoglycemias)
  • \- Chronic renal insufficiency with GFR \< 60 (stage III according to NKF)
  • \- Coronary artery disease with Z.n. intervention within the last 2 years or further complaints
  • \- Permanent anticoagulation with heart valve replacement
  • \- Dementia or other neurological diseases with alteration of gait (Parkinson's syndrome, myasthenia gravis, visual pathway disorders, etc.)
  • \- Anemia/hemophilia/thrombophilia with secondary DVT/LAE
  • \- Known depression/psychoaffective disorder
  • \- Chronic pain patient with long\-term opioid medication/fibromyalgia

Outcomes

Primary Outcomes

Not specified

Similar Trials